CHICAGO – Startup bioinformatics vendor Deep Lens is now integrating molecular data into its core platform for clinical trial screening and enrollment, thanks to an exclusive deal to license technology developed at the University of Miami.
Last month, Columbus, Ohio-based Deep Lens licensed an integration engine developed by the Sylvester Comprehensive Cancer Center and UHealth Information Technology, both part of the University of Miami.
Get the full story with
GenomeWeb Premium
Only $95 for the
first 90 days*
GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives
Never miss another important industry story.
Try GenomeWeb Premium now.
You may already have institutional access!
Check if I qualify.
Already a GenomeWeb or 360Dx Premium member?
Login Now.
*Before your trial expires, we’ll put together a custom quote with your long-term premium options.
